Indiana Trust & Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.6K Buy
+420
New +$79K 0.02% 254
2026
Q1
Sell
-341
Closed -$62.6K 489
2025
Q4
$62.6K Hold
341
0.02% 274
2025
Q3
$52.2K Hold
341
0.02% 289
2025
Q2
$47.6K Hold
341
0.02% 295
2025
Q1
$50.1K Hold
341
0.02% 290
2024
Q4
$44.6K Hold
341
0.02% 299
2024
Q3
$53.1K Hold
341
0.02% 291
2024
Q2
$53.1K Buy
+341
New +$51.3K 0.02% 277

Other funds holding AZN

Indiana Trust & Investment Management's AZN Position: Q2 2026 in Review

Indiana Trust & Investment Management opened a new position in AstraZeneca (AZN) in Q2 2026: 420 shares worth $78.6K. The stake represents 0.02% of the portfolio and ranks #254 among its holdings. This is a return to the name: Indiana Trust & Investment Management previously reported a position in AZN as recently as Q4 2025.

Indiana Trust & Investment Management first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 880 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Indiana Trust & Investment Management held 420 shares of AstraZeneca worth $78.6K as of Q2 2026.
  • AstraZeneca was a new Indiana Trust & Investment Management position in Q2 2026.
  • AstraZeneca made up 0.02% of Indiana Trust & Investment Management's portfolio in Q2 2026, its #254 holding.
  • Indiana Trust & Investment Management first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
  • 880 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Indiana Trust & Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.